Zenith Drugs, which was entirely a fresh equity issue of 51.48 lakh shares, received a healthy response from investors. The issue was subscribed 179 times, driven by strong interest across categories. The net proceeds will be used for the purchase of machinery and setting up a new plant, existing manufacturing block upgradation, working capital requirements, and general corporate purposes.
The news triggered strong buying action in the counter with 5.75 crore shareschanging hands on the NSE around 10.45 am with the traded value of the shares standing at Rs 292.89 crore around this time.
Overall, the bulls are likely to maintain their strong hold over Dalal Street though there may be volatility and consolidation due to the monthly expiry of February futures & options contracts scheduled on February 29.
Juniper Hotels, owned by Saraf Hotels and Hyatt Hotels Corporation, will debut on the bourses on February 28, while the trading in GPT Healthcare equity shares will commence with effect from February 29.